SIA Dr Letnikovs Longevity MedicineActive
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedPaid out in dividends approximately 25 000 € (8% of equity at the end of the previous year).
Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).
Summary of financial statements2017–2025
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||
| Total current assets | 43 154 | 94 558 | 192 570 | 231 163 | 132 228 | 72 284 | 129 339 | 124 577 | 186 406 |
| Total non-current assets | 0 | 0 | 54 600 | 42 000 | 130 900 | 224 175 | 185 624 | 204 066 | 218 876 |
| Total assets | 43 154 | 94 558 | 247 170 | 273 163 | 263 128 | 296 459 | 314 963 | 328 643 | 405 282 |
| Balance sheet — liabilities and equity | |||||||||
| Current liabilities | 0 | 50 302 | 104 449 | 40 181 | 28 725 | 18 711 | 6982 | 6358 | 3091 |
| Non-current liabilities | 48 503 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 48 503 | 50 302 | 104 449 | 40 181 | 28 725 | 18 711 | 6982 | 6358 | 3091 |
| Share capital | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — |
| Profit for the year | -8149 | 49 605 | 98 465 | 100 260 | 11 421 | 46 345 | 40 233 | 44 304 | 104 906 |
| Total equity | -5349 | 44 256 | 142 721 | 232 982 | 234 403 | 277 748 | 307 981 | 322 285 | 402 191 |
| Income statement | |||||||||
| Sales revenue | 3993 | 134 263 | 205 672 | 191 407 | 101 736 | 153 636 | 190 673 | 196 534 | 242 274 |
| Operating profit | -8149 | 49 605 | 98 465 | 101 538 | 13 921 | 47 095 | 42 733 | 51 804 | 111 156 |
| Profit before income tax | -8149 | 49 605 | 98 465 | 101 538 | 13 921 | 47 095 | 42 733 | 51 804 | 111 156 |
| Profit for the reporting year | -8149 | 49 605 | 98 465 | 100 260 | 11 421 | 46 345 | 40 233 | 44 304 | 104 906 |
| Labour costs | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — |
| Other indicators | |||||||||
| Employees | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| Calculated dividend | — | 0 | 0 | 9999 | 10 000 | 3000 | 10 000 | 30 000 | 25 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
Summary: SIA Dr Letnikovs Longevity Medicine
Overview
SIA Dr Letnikovs Longevity Medicine (reg. no. 50203106161) is a limited liability company. The company was registered in 2017 and has been in the register for 8 years. Registered address: Jūrmala, Lielupes iela 18 - 6.
Financial results
Revenue in 2025 was 242 274 €, up 23,3% on the previous year (196 534 €). From 2017 to 2025, revenue grew by an average of 67,1% per year. This is the company's highest revenue among the published years (2017–2025). Net profit for 2025 was 104 906 € (43,3% of revenue). The company was profitable in 8 of the 9 published years. In 2025 the company had 1 employees. Revenue per employee was 242 274 €. At the end of 2025, total assets were 405 282 € and equity 402 191 € (99,2% of assets).
Management and owners
The company has one board member. The sole owner of the company is a private individual.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.